Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 21501-21550 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06371040
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
PHASE1Recruiting
9 participants
Started: Jul 12, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06532708
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
NARecruiting
12 participants
Started: Jul 12, 2024 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT06454357
A Clinical Study of B007 in the Treatment of Pemphigus.
PHASE2/PHASE3Recruiting
132 participants
Started: Jul 12, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors12 locations
NCT06463561
CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea
PHASE4Recruiting
220 participants
Started: Jul 12, 2024 · Completed: Jan 31, 2028
3 conditions2 sponsors1 location
NCT06491615
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
N/ARecruiting
1,000 participants
Started: Jul 12, 2024 · Completed: Jun 27, 2054
7 conditions1 sponsor2 locations
NCT06517511
Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)
PHASE2Recruiting
42 participants
Started: Jul 11, 2024 · Completed: Apr 30, 2028
1 condition2 sponsors2 locations
NCT06383767
A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
PHASE3Recruiting
378 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT06386887
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
NARecruiting
20 participants
Started: Jul 11, 2024 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT06264700
Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness
NARecruiting
60 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2025
1 condition5 sponsors3 locations
NCT06462417
Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis
NARecruiting
15 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors2 locations
NCT06277037
Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
N/ARecruiting
50 participants
Started: Jul 11, 2024 · Completed: Oct 30, 2029
1 condition1 sponsor18 locations
NCT06455254
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
PHASE2Recruiting
44 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT06434610
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
PHASE2Recruiting
90 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors17 locations
NCT06229873
Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure
PHASE1Recruiting
96 participants
Started: Jul 11, 2024 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT06983119
Case-Finding for Neurocognitive Disorders in Pavia
NARecruiting
490 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06334822
Randomised Controlled Trial for Assessing the Effectiveness of an Inclusive Heart Failure Monitoring and TRACKing Solution in the UK.
NARecruiting
270 participants
Started: Jul 11, 2024 · Completed: Jul 30, 2025
1 condition1 sponsor9 locations
NCT06264180
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
PHASE3Recruiting
400 participants
Started: Jul 11, 2024 · Completed: Aug 31, 2034
1 condition1 sponsor49 locations
NCT05866562
Dupilumab in the Treatment of Pediatric Alopecia Areata
PHASE2Recruiting
76 participants
Started: Jul 11, 2024 · Completed: May 30, 2029
1 condition1 sponsor4 locations
NCT06392906
Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)
PHASE3Recruiting
68 participants
Started: Jul 11, 2024 · Completed: Oct 31, 2028
1 condition2 sponsors1 location
NCT06577844
Evaluation of the Contribution of a DEMaterialized VIdeo-pedagogical SUpport in the Care Pathway of Lung Cancer Surgery Patients
NARecruiting
226 participants
Started: Jul 11, 2024 · Completed: Apr 11, 2026
1 condition1 sponsor1 location
NCT06482190
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers
PHASE1Recruiting
72 participants
Started: Jul 11, 2024 · Completed: Feb 10, 2025
2 conditions2 sponsors3 locations
NCT06362733
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
NARecruiting
44 participants
Started: Jul 11, 2024 · Completed: Jul 1, 2026
3 conditions1 sponsor1 location
NCT06263998
Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops
PHASE1Recruiting
60 participants
Started: Jul 11, 2024 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT06772701
Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
NARecruiting
1,000 participants
Started: Jul 11, 2024 · Completed: Sep 12, 2025
1 condition1 sponsor2 locations
NCT06342986
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
PHASE1Recruiting
33 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2027
4 conditions2 sponsors1 location
NCT06420167
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
PHASE2Recruiting
20 participants
Started: Jul 11, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06380517
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
PHASE3Recruiting
238 participants
Started: Jul 11, 2024 · Completed: May 1, 2027
1 condition3 sponsors70 locations
NCT06481943
A Prospective Research Investigation of Ischemia Using MCG
N/ARecruiting
150 participants
Started: Jul 11, 2024 · Completed: Apr 30, 2026
1 condition3 sponsors2 locations
NCT06439888
Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer
PHASE1/PHASE2Recruiting
58 participants
Started: Jul 11, 2024 · Completed: Jan 31, 2027
2 conditions1 sponsor2 locations
NCT06212076
Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients
PHASE1/PHASE2Recruiting
60 participants
Started: Jul 11, 2024 · Completed: Jul 9, 2027
1 condition1 sponsor2 locations
NCT06515275
Video-Supported Medication Education for Women Undergoing In Vitro Fertilization (IVF): Quality of Life and Psychosocial Effects
NARecruiting
60 participants
Started: Jul 11, 2024 · Completed: Jul 15, 2025
5 conditions1 sponsor1 location
NCT06340685
Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency
PHASE1Recruiting
6 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06445023
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
PHASE3Recruiting
915 participants
Started: Jul 11, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor230 locations
NCT06187077
Techquity by FAITH!
NARecruiting
200 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2026
2 conditions4 sponsors1 location
NCT06287229
Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
PHASE1/PHASE2Recruiting
40 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT06379724
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
PHASE4Recruiting
62 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06109142
Clearance of Vasoactive Metabolites With Blood Purification
N/ARecruiting
30 participants
Started: Jul 11, 2024 · Completed: Jun 11, 2026
1 condition1 sponsor3 locations
NCT06091202
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
PHASE3Recruiting
608 participants
Started: Jul 11, 2024 · Completed: Jun 1, 2027
1 condition6 sponsors4 locations
NCT07145138
UIC Multi-Ethnic DCM Registry
N/ARecruiting
1,500 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2038
2 conditions1 sponsor1 location
NCT06374875
Fibrosis Lessens After Metabolic Surgery
PHASE4Recruiting
120 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2029
5 conditions2 sponsors22 locations
NCT06515795
Evaluation of Two Isometric Exercises in the Reduction of the Blood Pressure in People With Resistant Hypertension
NARecruiting
15 participants
Started: Jul 11, 2024 · Completed: Sep 30, 2024
1 condition2 sponsors1 location
NCT05662462
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
NARecruiting
124 participants
Started: Jul 11, 2024 · Completed: Mar 31, 2029
4 conditions3 sponsors1 location
NCT06500819
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
PHASE1Recruiting
41 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2029
3 conditions1 sponsor1 location
NCT06601309
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
PHASE2Recruiting
90 participants
Started: Jul 11, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06319846
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
PHASE3Recruiting
4,674 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor5 locations
NCT06513234
Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas
PHASE2Recruiting
45 participants
Started: Jul 11, 2024 · Completed: Jun 21, 2029
1 condition1 sponsor1 location
NCT06507579
Hydra Registry - UK
N/ARecruiting
250 participants
Started: Jul 11, 2024 · Completed: Aug 1, 2026
1 condition2 sponsors4 locations
NCT06558981
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
PHASE3Recruiting
124 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2031
1 condition1 sponsor1 location
NCT06562114
A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment
PHASE1Recruiting
72 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06441591
Clinical Outcome of Vinpocetine in Diabetic Nephropathy
PHASE2/PHASE3Recruiting
64 participants
Started: Jul 10, 2024 · Completed: Jun 1, 2025
2 conditions1 sponsor2 locations